14.04.24 | Vollzeit, Teilzeit | Dachau | Medipolis UnternehmensgruppeVon Kunden (Kliniken u. ambulanten ärztlichen Einrichtungen) im Bereich parenterale Ernährung, Schmerztherapie, Antibiose Versorgung und Portversorgung in Zusammenarbeit mit unseren Vertriebsmitarbeitern - Sie sind ein/e medizinische/r Pflege-Experte/in (m/w/d). - Sie verfügen über eine abgeschlossene
Später ansehen08.04.24 | Vollzeit | Dachau | CatalYm GmbHIs markedly overexpressed across various tumor types. This novel approach has demonstrated the ability to reinvigorate anti-tumor immune responses and produce clinically significant outcomes in patients previously unresponsive to immunotherapy. Building upon highly promising results from Phase 2 clinical
Später ansehen08.04.24 | Vollzeit | Dachau | CatalYm GmbHIs markedly overexpressed across various tumor types. This novel approach has demonstrated the ability to reinvigorate anti-tumor immune responses and produce clinically significant outcomes in patients previously unresponsive to immunotherapy. Building upon highly promising results from Phase 2 clinical
Später ansehen08.04.24 | Vollzeit | Dachau | CatalYm GmbHIs markedly overexpressed across various tumor types. This novel approach has demonstrated the ability to reinvigorate anti-tumor immune responses and produce clinically significant outcomes in patients previously unresponsive to immunotherapy. Building upon highly promising results from Phase 2 clinical
Später ansehen08.04.24 | Vollzeit | Dachau | CatalYm GmbHIs markedly overexpressed across various tumor types. This novel approach has demonstrated the ability to reinvigorate anti-tumor immune responses and produce clinically significant outcomes in patients previously unresponsive to immunotherapy. Building upon highly promising results from Phase 2 clinical
Später ansehen08.04.24 | Vollzeit | Dachau | CatalYm GmbHIs markedly overexpressed across various tumor types. This novel approach has demonstrated the ability to reinvigorate anti-tumor immune responses and produce clinically significant outcomes in patients previously unresponsive to immunotherapy. Building upon highly promising results from Phase 2 clinical
Später ansehen08.04.24 | Vollzeit | Dachau | CatalYm GmbHIs markedly overexpressed across various tumor types. This novel approach has demonstrated the ability to reinvigorate anti-tumor immune responses and produce clinically significant outcomes in patients previously unresponsive to immunotherapy. Building upon highly promising results from Phase 2 clinical
Später ansehen08.04.24 | Vollzeit | Dachau | CatalYm GmbHIs markedly overexpressed across various tumor types. This novel approach has demonstrated the ability to reinvigorate anti-tumor immune responses and produce clinically significant outcomes in patients previously unresponsive to immunotherapy. Building upon highly promising results from Phase 2 clinical
Später ansehen08.04.24 | Vollzeit | Dachau | CatalYm GmbHIs markedly overexpressed across various tumor types. This novel approach has demonstrated the ability to reinvigorate anti-tumor immune responses and produce clinically significant outcomes in patients previously unresponsive to immunotherapy. Building upon highly promising results from Phase 2 clinical
Später ansehenVerpassen Sie nie wieder einen passenden Job!
Alle Jobs für Anti in Dachau kostenlos abonnieren.